OABI Competitors & Alternatives
Compare OmniAb Inc. with similar stocks in the same industry
Biotechnology
OABI
Main Stock$2.11
Tradestie Score
58
Market Cap
$231.77M
Revenue Growth
2.5%
Analyst Upside
+247.5%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LRMR
Larimar Therapeutics, Inc. Common Stock
|
$3.78
|
$355.20M | - | 58 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$18.17
|
$354.45M | - | 58 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$32.30
|
$353.70M | - | 57 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.58
|
$350.98M | - | 48 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.97
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.64
|
$332.96M | - | 64 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.86
|
$328.62M | - | 55 | Compare |
|
PEPG
PepGen Inc. Common Stock
|
$2.43
|
$323.75M | - | 57 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.15
|
$319.22M | - | 54 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.83
|
$308.74M | - | 60 | Compare |
More OABI Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 8731)
234 stocks in this industry